GMA News
DOH: Over 230,000 minors vaccinated vs COVID-19
As of November 8, 2021, 230,357 minors aged 12 to 17 have received COVID-19 vaccines in the Philippines.
This figure represents the total vaccinated minors under the pediatric inoculation program.
Approximately 0.10% of these vaccinated minors experienced adverse events following immunization (AEFIs).
The most frequently reported AEFIs are expected temporary reactions such as vaccination site pain, headaches, and dizziness, with some anxiety-related cases also reported.
Health Undersecretary Maria Rosario Vergeire stated that all adverse event cases were managed, and adolescents who experienced reactions were able to go home after proper treatment.
The nationwide pediatric vaccination officially launched on November 3, 2021, following a pilot rollout for minors with comorbidities.
The government aims to vaccinate 80% of the 12.7 million minors aged 12 to 17 by December 2021.
Only Pfizer and Moderna vaccines are authorized for pediatric vaccinations in the country.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines commenced its COVID-19 vaccination program for minors aged 12 to 17 on November 3, with a nationwide rollout beginning November 5.
Read more →
Over 20,000 minors in Manila have received their first dose of vaccine against COVID-19 as of November 6.
Read more →
Manila began its general COVID-19 vaccination for minors aged 12 to 17 on Wednesday, November 3, at six designated hospitals.
Read more →
The local government of Santo Tomas in Davao del Norte has begun its vaccination drive for individuals aged 12 to 17 years old against COVID-19, aiming to vaccinate approximately 8,000 children.
Read more →
The Food and Drug Administration (FDA) reported that no severe adverse effects have been observed among children aged 12 to 17 who have received their initial COVID-19 vaccine doses.
Read more →